Teriparatide oral (Entera Bio)

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameTeriparatide oral (Entera Bio)
Drug Alias NamePTH(1-34) PeptideOral hPTH(1-34)Oral PTH (1-34)oral PTH(1-34)teriparatide (Entera Bio) +[16] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsFractures, StressDrug-Related Side Effects and Adverse ReactionsHypoparathyroidism +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEntera Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEntera Bio Ltd
Inactive CompaniesN/A
Active IndicationsFractures, StressOsteoporosis
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsHypoparathyroidism

Other Information

ATC CodeN/A
Related LinksN/A